AbbVie (ABBV) Shares Outstanding (Weighted Average) (2012 - 2026)

AbbVie (ABBV) has 15 years of Shares Outstanding (Weighted Average) data on file, last reported at $1.8 billion in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $1.8 billion, changed 0.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 billion (changed 0.11% YoY), and the FY2025 annual result was $1.8 billion, changed 0.0% from the prior year.
• Shares Outstanding (Weighted Average) was little changed at $1.8 billion in Q1 2026 per ABBV's latest filing, from $1.8 billion in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $1.8 billion in Q1 2022 and troughed at $1.8 billion in Q2 2023.
• A 5-year average of $1.8 billion and a median of $1.8 billion in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Weighted Average) slipped 0.17% in 2023, then climbed 0.11% in 2026.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $1.8 billion in 2022, then slipped by 0.17% to $1.8 billion in 2023, then gained by 0.06% to $1.8 billion in 2024, then changed by 0.0% to $1.8 billion in 2025, then increased by 0.06% to $1.8 billion in 2026.
• Business Quant data shows ABBV's Shares Outstanding (Weighted Average) at $1.8 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.8 billion in Q3 2025.